Log in to save to my catalogue

An immunogenic personal neoantigen vaccine for patients with melanoma

An immunogenic personal neoantigen vaccine for patients with melanoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1920222004

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The results of a phase I trial assessing a personal neoantigen multi-peptide vaccine in patients with melanoma, showing feasibility, safety, and immunogenicity.
Personalized cancer vaccine trials
Neoantigens have long been considered optimal targets for anti-tumour vaccines, and recent mutation coding and prediction techniques have aimed to s...

Alternative Titles

Full title

An immunogenic personal neoantigen vaccine for patients with melanoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1920222004

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1920222004

Other Identifiers

ISSN

0028-0836

E-ISSN

1476-4687

DOI

10.1038/nature22991

How to access this item